Spyre Therapeutics, Inc.

NASDAQ:SYRE

Biotechnology

Healthcare
$97.63 +1.38%

+$1.21 today

Market cap
$9.27B
Beta
3.06
P/E (TTM)
-171.1
EPS (TTM)
-$0.52
52W Low $14.00High $91.04

Volume 0.63M

Average 1.17M

Price history

Spyre Therapeutics, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+315.98%

Period high

$109.00

Period low

$23.47

Latest

$97.63

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
8-KNov 3, 2026Nov 3, 2026
10-QNov 3, 2026Nov 3, 2026
SC 13D/AOct 9, 2026Oct 9, 2026
8-KOct 7, 2026Oct 7, 2026
424B5Oct 6, 2026Oct 6, 2026
424B5Oct 5, 2026Oct 5, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
4Oct 2, 2026Oct 2, 2026
SC 13GOct 1, 2026Oct 1, 2026
8-KSep 8, 2026Sep 8, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
4Sep 3, 2026Sep 3, 2026
144Sep 1, 2026Sep 1, 2026

Competitors

Who does Spyre Therapeutics, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about SYRE's filings, answered from its disclosures.

What is the latest SYRE filing?

The latest filing shown is 10-Q dated Nov 3, 2026.

How many recent filings does SYRE have?

Intrinsic Alpha currently shows 20 recent filings for SYRE.